• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数对根治性手术后进展期胃癌术后结局的影响。

Impact of body mass index on postoperative outcome of advanced gastric cancer after curative surgery.

机构信息

Division of General Surgery, Department of Surgery, Taipei Veterans General Hospital, 201 Section 2 Shih-Pai Road, Taipei, 11217, Taiwan.

出版信息

J Gastrointest Surg. 2013 Aug;17(8):1382-91. doi: 10.1007/s11605-013-2238-x. Epub 2013 May 29.

DOI:10.1007/s11605-013-2238-x
PMID:23715652
Abstract

INTRODUCTION

The impact of body mass index (BMI) on the outcome of advanced gastric cancer surgery is controversial. Between December 1987 and December 2006, a total of 947 advanced gastric cancer patients receiving curative resection with retrieved lymph node number >15 were studied and divided into three groups according to BMI (<25, 25-30, and >30 kg/m(2)).

RESULTS AND DISCUSSION

With regard to comorbidities present prior to surgery, higher BMI patients were more likely to have heart disease, type 2 diabetes, and hypertension than lower BMI patients. Compared with BMI <25 kg/m(2), higher BMI patients had longer operative time and more surgery-related morbidity. Multivariate Cox proportional-hazard analysis showed that age, pathological T and N categories, and lymphovascular invasion were independent prognostic factors. The initial recurrence patterns, 5-year overall survival, and cancer-specific survival were similar among the three groups.

CONCLUSION

Only in stage III gastric cancer with BMI less than 25 kg/m(2) patients receiving total gastrectomy had a more advanced pathological N category and a worse prognosis compared to those receiving subtotal gastrectomy. Higher BMI was associated with longer operative time and more surgery-related morbidity than lower BMI. BMI alone is not an independent prognostic factor.

摘要

简介

体质量指数(BMI)对进展期胃癌手术结果的影响存在争议。1987 年 12 月至 2006 年 12 月,共对 947 例接受根治性切除术且淋巴结检出数>15 枚的进展期胃癌患者进行了研究,并根据 BMI(<25、25-30 和>30 kg/m²)将其分为三组。

结果与讨论

就术前并存疾病而言,BMI 较高的患者发生心脏病、2 型糖尿病和高血压的可能性高于 BMI 较低的患者。与 BMI<25 kg/m²相比,BMI 较高的患者手术时间更长,手术相关发病率更高。多变量 Cox 比例风险分析表明,年龄、病理 T 和 N 分期以及脉管侵犯是独立的预后因素。三组患者的初始复发模式、5 年总生存率和癌症特异性生存率相似。

结论

仅在 BMI<25 kg/m²的 III 期胃癌患者中,全胃切除术比次全胃切除术具有更晚期的病理 N 分期和更差的预后。与 BMI 较低的患者相比,BMI 较高的患者手术时间更长,手术相关发病率更高。BMI 本身不是独立的预后因素。

相似文献

1
Impact of body mass index on postoperative outcome of advanced gastric cancer after curative surgery.体重指数对根治性手术后进展期胃癌术后结局的影响。
J Gastrointest Surg. 2013 Aug;17(8):1382-91. doi: 10.1007/s11605-013-2238-x. Epub 2013 May 29.
2
Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.Ⅱ期胃癌中淋巴管和/或血管侵犯的影响。
World J Gastroenterol. 2012 Jul 21;18(27):3610-6. doi: 10.3748/wjg.v18.i27.3610.
3
Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.胃癌中免疫组化鉴定的淋巴管和/或血管肿瘤侵犯的临床意义。
J Surg Res. 2010 Aug;162(2):177-83. doi: 10.1016/j.jss.2009.07.015. Epub 2009 Aug 11.
4
Effect of body mass index in patients undergoing resection for gastric cancer: a single center US experience.体重指数对接受胃癌切除术患者的影响:美国单中心经验
J Gastrointest Surg. 2014 Mar;18(3):505-11. doi: 10.1007/s11605-014-2455-y. Epub 2014 Jan 18.
5
Prognostic significance of lymphovascular invasion in node-negative gastric cancer.淋巴结阴性胃癌中淋巴管侵犯的预后意义
World J Surg. 2015 Mar;39(3):732-9. doi: 10.1007/s00268-014-2846-y.
6
Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.不同时期行根治性胃切除术的胃癌患者术后复发变化及预后危险因素。
Ann Surg Oncol. 2013 Jul;20(7):2317-27. doi: 10.1245/s10434-012-2700-0. Epub 2013 May 16.
7
Survival impact of postoperative body mass index in gastric cancer patients undergoing gastrectomy.胃癌患者胃切除术后体重指数对生存的影响。
Eur J Cancer. 2016 Jan;52:129-37. doi: 10.1016/j.ejca.2015.10.061. Epub 2015 Dec 10.
8
Preoperative Low Weight Affects Long-term Outcomes Following Curative Gastrectomy for Gastric Cancer.术前低体重影响胃癌根治性胃切除术后的长期预后。
Anticancer Res. 2018 Sep;38(9):5331-5337. doi: 10.21873/anticanres.12860.
9
Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence.胃癌根治性切除术后淋巴结阴性转移患者的预后:生存与复发结果
Can J Gastroenterol. 2008 Oct;22(10):835-9. doi: 10.1155/2008/761821.
10
Effect of complication grade on survival following curative gastrectomy for carcinoma.并发症分级对胃癌根治性切除术后生存的影响。
World J Gastroenterol. 2014 Jul 7;20(25):8244-52. doi: 10.3748/wjg.v20.i25.8244.

引用本文的文献

1
The prognostic impact of body mass index on patients with gastric adenocarcinoma and mucinous adenocarcinoma: a retrospective cohort study.体重指数对胃腺癌和黏液腺癌患者的预后影响:一项回顾性队列研究。
J Gastrointest Oncol. 2025 Feb 28;16(1):41-52. doi: 10.21037/jgo-24-593. Epub 2025 Feb 26.
2
Long-term outcomes of laparoscopic versus open distal gastrectomy for patients with advanced gastric cancer in North China: a multicenter randomized controlled trial.中国北方地区进展期胃癌行腹腔镜与开腹远端胃癌根治术的长期疗效:一项多中心随机对照临床试验。
Surg Endosc. 2024 Sep;38(9):4976-4985. doi: 10.1007/s00464-024-10952-2. Epub 2024 Jul 9.
3

本文引用的文献

1
Initial experience of robotic gastrectomy and comparison with open and laparoscopic gastrectomy for gastric cancer.机器人胃癌根治术的初步经验及其与开腹和腹腔镜胃癌根治术的比较。
J Gastrointest Surg. 2012 Jul;16(7):1303-10. doi: 10.1007/s11605-012-1874-x. Epub 2012 Mar 27.
2
Risk factors and management of anastomotic leakage after radical gastrectomy for gastric cancer.胃癌根治性切除术后吻合口漏的危险因素及处理
Hepatogastroenterology. 2011 Jan-Feb;58(105):218-23.
3
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Impact of Body Mass Index on Survival Depending on Sex in 14,688 Patients with Gastric Cancer in a Tertiary Hospital in South Korea.
在韩国一家三级医院的 14688 例胃癌患者中,体重指数对生存的影响取决于性别。
Gut Liver. 2023 Mar 15;17(2):243-258. doi: 10.5009/gnl220104. Epub 2022 Nov 1.
4
Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor.体重指数与II/III期胃癌患者根治性胃切除术后的预后:围手术期辅助化疗的完成情况可能是一个混杂因素。
Front Oncol. 2022 Jun 13;12:899677. doi: 10.3389/fonc.2022.899677. eCollection 2022.
5
Low body mass index is an independent predictor of poor long-term prognosis among patients with resectable gastric cancer.低体重指数是可切除胃癌患者长期预后不良的独立预测因素。
World J Gastrointest Oncol. 2021 Mar 15;13(3):161-173. doi: 10.4251/wjgo.v13.i3.161.
6
Incidence and risk factors of postoperative complications after robotic gastrectomy for gastric cancer: an analysis of 817 cases based on 10-year experience in a large-scale center.基于大型中心 10 年经验的 817 例病例分析:机器人胃癌根治术后并发症的发生率及危险因素。
Surg Endosc. 2021 Dec;35(12):7034-7041. doi: 10.1007/s00464-020-08218-8. Epub 2021 Jan 25.
7
Morbidity and short-term surgical outcomes of robotic versus laparoscopic distal gastrectomy for gastric cancer: a large cohort study.机器人与腹腔镜远端胃癌根治术治疗胃癌的发病率和短期手术结局:一项大样本队列研究。
Surg Endosc. 2021 Jul;35(7):3572-3583. doi: 10.1007/s00464-020-07820-0. Epub 2020 Jul 20.
8
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study.二线雷莫芦单抗治疗晚期胃癌患者的体重减轻和体重指数:一项真实世界多中心研究。
J Cancer Res Clin Oncol. 2019 Sep;145(9):2365-2373. doi: 10.1007/s00432-019-02971-7. Epub 2019 Jul 6.
9
Overweight or Obesity is an Unfavorable Long-Term Prognostic Factor for Patients who Underwent Gastrectomy for Stage II/III Gastric Cancer.超重或肥胖是行 II/III 期胃癌根治术患者的不利长期预后因素。
World J Surg. 2019 Jul;43(7):1766-1776. doi: 10.1007/s00268-019-04969-1.
10
Dislocation of intra-abdominal drains after pancreatic surgery: results of a prospective observational study.胰腺手术后腹腔引流管脱位:一项前瞻性观察性研究的结果
Langenbecks Arch Surg. 2019 Mar;404(2):213-222. doi: 10.1007/s00423-019-01760-7. Epub 2019 Feb 15.
2010年美国心脏病学会基金会/美国心脏协会无症状成年人心血管风险评估指南:执行摘要:美国心脏病学会基金会/美国心脏协会实践指南工作组报告
Circulation. 2010 Dec 21;122(25):2748-64. doi: 10.1161/CIR.0b013e3182051bab. Epub 2010 Nov 15.
4
Implications of overweight in gastric cancer: A multicenter study in a Western patient population.超重对胃癌的影响:一项针对西方患者群体的多中心研究。
Eur J Surg Oncol. 2010 Oct;36(10):969-76. doi: 10.1016/j.ejso.2010.07.007. Epub 2010 Aug 21.
5
Better 5-year survival rate following curative gastrectomy in overweight patients.超重患者行根治性胃切除术后 5 年生存率更好。
Ann Surg Oncol. 2009 Dec;16(12):3245-51. doi: 10.1245/s10434-009-0645-8.
6
Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies.超重、肥胖与胃癌风险:基于队列研究的荟萃分析结果。
Eur J Cancer. 2009 Nov;45(16):2867-73. doi: 10.1016/j.ejca.2009.04.019. Epub 2009 May 6.
7
Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma.超重对近端胃癌术后发病率及长期手术结局的影响
J Gastroenterol Hepatol. 2009 Mar;24(3):475-9. doi: 10.1111/j.1440-1746.2008.05704.x. Epub 2008 Nov 27.
8
Risk factors and management of intra-abdominal infection after extended radical gastrectomy.扩大根治性胃切除术后腹腔内感染的危险因素及管理
Am J Surg. 2008 Nov;196(5):741-5. doi: 10.1016/j.amjsurg.2007.11.031.
9
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.体重指数与癌症发病率:前瞻性观察性研究的系统评价与荟萃分析
Lancet. 2008 Feb 16;371(9612):569-78. doi: 10.1016/S0140-6736(08)60269-X.
10
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.使用口服氟嘧啶S-1对胃癌进行辅助化疗。
N Engl J Med. 2007 Nov 1;357(18):1810-20. doi: 10.1056/NEJMoa072252.